双星药业 (871824.OC)

+ 收藏

现金流量表(双星药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 31,818,913.8550,462,165.5917,958,598.6146,103,251.2418,807,643.71
 收到的税费返还(元) -509.22---
 收到其他与经营活动有关的现金(元) 23,109,575.6832,876,227.8012,259,036.8616,200,025.2315,388,802.03
 经营活动现金流入小计(元) 54,928,489.5383,338,902.6130,217,635.4762,303,276.4734,196,445.74
 购买商品、接受劳务支付的现金(元) 13,511,140.6836,625,732.3113,309,619.7521,530,299.8115,904,255.96
 支付给职工以及为职工支付的现金(元) 2,001,524.723,558,372.152,292,390.373,250,908.391,239,631.97
 支付的各项税费(元) 3,316,091.514,890,385.642,842,061.059,100,185.913,316,985.91
 支付其他与经营活动有关的现金(元) 19,404,597.6720,141,881.9213,803,646.0518,494,028.7415,396,416.71
 经营活动现金流出小计(元) 38,233,354.5865,216,372.0232,247,717.2252,375,422.8535,857,290.55
 经营活动产生的现金流量净额(元) 16,695,134.9518,122,530.59-2,030,081.759,927,853.62-1,660,844.81
二、投资活动产生的现金流量
 购建固定资产、无形资产和其他长期资产支付的现金(元) 17,935,018.8124,523,005.0012,756,120.8121,513,121.97102,942.81
 投资活动现金流出小计(元) 17,935,018.8124,523,005.0012,756,120.8121,513,121.97102,942.81
 投资活动产生的现金流量净额(元) -17,935,018.81-24,523,005.00-12,756,120.81-21,513,121.97-102,942.81
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) ---10,000,000.0010,000,000.00
 取得借款收到的现金(元) 24,489,000.0033,289,000.0014,489,000.0024,390,413.004,590,413.00
 筹资活动现金流入小计(元) 24,489,000.0033,289,000.0014,489,000.0034,390,413.0014,590,413.00
 偿还债务支付的现金(元) 13,489,000.0023,800,000.001,450,000.0011,990,413.001,590,413.00
 分配股利、利润或偿付利息支付的现金(元) 845,106.431,422,843.14648,220.92500,429.11216,365.77
 支付其他与筹资活动有关的现金(元) 1,494.002,559,041.602,266,557.842,276,557.842,169,357.84
 筹资活动现金流出小计(元) 14,335,600.4327,781,884.744,364,778.7614,767,399.953,976,136.61
 筹资活动产生的现金流量净额(元) 10,153,399.575,507,115.2610,124,221.2419,623,013.0510,614,276.39
五、现金及现金等价物净增加额(元) 8,913,515.71-893,359.15-4,661,981.328,037,744.708,850,488.77
 加:期初现金及现金等价物余额(元) 14,162,512.7615,055,871.9115,055,871.917,018,127.217,018,127.21
 期末现金及现金等价物余额(元) 23,076,028.4714,162,512.7610,393,890.5915,055,871.9115,868,615.98
补充资料:
 净利润(元) 9,526,155.7113,949,006.815,871,241.8215,933,675.469,945,891.66
 资产减值准备(元) -92,885.85-257,867.52-153,799.47845,007.17995,167.05
 固定资产和投资性房地产折旧(元) 2,234,671.613,203,256.991,370,878.842,515,944.501,277,616.96
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 2,234,671.613,203,256.991,370,878.842,515,944.501,277,616.96
 无形资产摊销(元) 1,239,223.56694,611.7549,999.9899,999.9649,999.98
 长期待摊费用摊销(元) 3,194,700.725,918,267.942,723,567.223,391,980.961,695,990.48
 财务费用(元) 845,106.431,463,845.06648,220.92536,889.74216,365.77
 递延所得税(元) -139,554.93-58,564.30-217,572.04-215,821.08-149,275.05
  其中:递延所得税资产减少(元) -139,554.93246,042.98-217,572.04-215,821.08-149,275.05
 递延所得税负债增加(元) --304,607.28---
 存货的减少(元) -5,532,709.031,422,573.85-2,079,421.491,215,368.28-912,640.10
 经营性应收项目的减少(元) -2,887,430.93-13,282,231.43-15,406,825.96-11,716,737.03-14,641,028.62
 经营性应付项目的增加(元) 5,199,101.072,401,213.632,544,291.08-5,241,482.31-1,089,567.12
 现金的期末余额(元) 23,076,028.4714,162,512.7610,393,890.5915,055,871.9115,868,615.98
 减:现金的期初余额(元) 14,162,512.7615,055,871.9115,055,871.917,018,127.217,018,127.21
 现金及现金等价物的净增加额(元) 8,913,515.71-893,359.15-4,661,981.328,037,744.708,850,488.77
公告日期 2024-08-282024-04-252023-08-292023-04-272022-08-26
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院